Rivaroxaban Market Size to Soar at 9.4% CAGR to 2023 Dominated by Bayer Pharmaceuticals

Researchbeam.com has added a new “2018-2023 Global Rivaroxaban Consumption Market Report” focusing on global major leading players with information such as company profiles, market trend, share and forecast.

Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8 to 12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.

Request a sample copy of this research report: https://www.researchbeam.com/2018-2023-global-rivaroxaban-consumption-report-market/request-sample?utm_source=OPR&utm_medium=CC

The global average price of Rivaroxaban is in the decreasing trend, from 5.62 USD/Unit in 2011 to 5.34 USD/Unit in 2015. With the situation of global economy, prices will be in slowly decreasing trend in the following five years.

Bayer is the only supplier of Rivaroxaban enjoying production market share100% in 2015 and it will still in this situation until 2023.

Over the next five years, the research study projects that Rivaroxaban will register a 9.4% CAGR in terms of revenue, reach US$ 10100 million by 2023, from US$ 5860 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Rivaroxaban market by product type, application, key manufacturers and key regions. To calculate the market size, research study considers value and volume generated from the sales of the following segments: Segmentation by product type are 2.5mg, 10mg, 15mg and 20mg. Segmentation by application are Acute Coronary Syndrome (ACS) and Venous Thromboembolism (VTE).

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report such as Bayer, J&J and more.

Get a discount on this research report: https://www.researchbeam.com/2018-2023-global-rivaroxaban-consumption-report-market/purchase-enquiry?utm_source=OPR&utm_medium=CC

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Related Report:

2018-2023 Global Acetylcysteine Consumption Market Report

Acetylcysteine, also known as N-acetylcysteine (NAC), is a modified amino acid that is used as an antidote for acetaminophen overdose to prevent hepatic injury. Acetylcysteine is a hepatoprotective agent and has not been linked to significant serum enzyme elevations during therapy or to instances of clinically apparent acute liver injury.

Over the next five years, the research study projects that Acetylcysteine will register a 22.3% CAGR in terms of revenue, reach US$ 1650 million by 2023, from US$ 490 million in 2017.

Global major consumption regions are distributed in USA, Europe and India. In 2016, Europe consumed about 3908.2 MT acetylcysteine. USA and India separately consumed about 3005.4 MT and 1392.3 MT in 2016. Meanwhile, most acetylcysteine API suppliers also produce downstream medicine directly, especially most Europe and India suppliers.

Read More: https://www.researchbeam.com/2018-2023-global-acetylcysteine-consumption-report-market?utm_source=OPR&utm_medium=CC

About Us:

Research Beam is a high end and wide online market for market research reports that contain detailed and rational market research. Research Beam is a one stop report destination that offers clients well drafted and accurately analyzed report with insightful data.

We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. Research Beam will always make sure to bring most ethical and high quality reports. We value your relationship with us and look forward for a long term relation.

Contact Us
Global Head Quarters
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
+1 (800) 910-6452
help@researchbeam.com

This release was published on openPR.